Literature DB >> 27333324

Rab7 induces clearance of α-synuclein aggregates.

Elisabeth Dinter1, Theodora Saridaki1, Markus Nippold1, Sarah Plum2, Leonie Diederichs1, Daniel Komnig1, Luisa Fensky1, Caroline May2, Katrin Marcus2, Aaron Voigt1, Jörg B Schulz1,3, Björn H Falkenburger1,3.   

Abstract

Parkinson's disease can be caused by mutations in the α-synuclein gene and is characterized by aggregates of α-synuclein protein. Aggregates are degraded by the autophago-lysosomal pathway. Since Rab7 has been shown to regulate trafficking of late endosomes and autophagosomes, we hypothesized that over-expressing Rab7 might be beneficial in Parkinson's disease. To test this hypothesis, we expressed the pathogenic A53T mutant of α-synuclein in HEK293 cells and Drosophila melanogaster. In HEK293 cells, EGFP-Rab7-decorated vesicles contain α-synuclein. Rab7 over-expression reduced the percentage of cells with α-synuclein particles and the amount of α-synuclein protein. Time-lapse microscopy confirmed that particles frequently disappeared with Rab7 over-expression. Clearance of α-synuclein is explained by the increased occurrence of acidified α-synuclein vesicles with Rab7 over-expression, presumably representing autolysosomes. Rab7 over-expression reduced apoptosis and the percentage of dead cells in trypan blue staining. In the fly model, Rab7 rescued the locomotor deficit induced by neuronal expression of A53T-α-synuclein. These beneficial effects were not produced by Rab7 missense mutations causing Charcot Marie Tooth neuropathy, or by the related GTPases Rab5, Rab9, or Rab23. Using mass spectrometry, we identified Rab7 in neuromelanin granules purified from human substantia nigra, indicating that Rab7 might be involved in the biogenesis of these possibly protective, autophagosome-like organelles in dopaminergic neurons. Taken together, Rab7 increased the clearance of α-synuclein aggregates, reduced cell death, and rescued the phenotype in a fly model of Parkinson's disease. These findings indicate that Rab7 is rate-limiting for aggregate clearance, and that Rab7 activation may offer a therapeutic strategy for Parkinson's disease. Cells over-expressing aggregation-prone A53T alpha-synuclein develop cytoplasmic aggregates mimicking changes observed in Parkinson's disease. When following cells in time-lapse microscopy, some few cells are able to remove these aggregates (Opazo et al. 2008). We now show that the percentage of cells clearing all aggregates from their cytosol is greatly increased with Rab7 over-expression, indicating that availability of Rab7 is rate-limiting for autophagic clearance of aggregates. The functional significance of this effect in neurons was confirmed in a Drosophila melanogaster model of Parkinson's disease.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  Rab7; acidification; autophagy; time-lapse microscopy; α-synuclein

Mesh:

Substances:

Year:  2016        PMID: 27333324     DOI: 10.1111/jnc.13712

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

1.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.

Authors:  Edward F Griffin; Xiaohui Yan; Kim A Caldwell; Guy A Caldwell
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

Review 3.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

4.  RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson's disease under chronic restraint stress.

Authors:  Zhao Zhang; Shi-Feng Chu; Sha-Sha Wang; Yi-Na Jiang; Yan Gao; Peng-Fei Yang; Qi-Di Ai; Nai-Hong Chen
Journal:  Br J Pharmacol       Date:  2018-01-17       Impact factor: 8.739

Review 5.  Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance.

Authors:  Subhashree Sahoo; Amrita Arpita Padhy; Varsha Kumari; Parul Mishra
Journal:  Mol Neurobiol       Date:  2022-06-14       Impact factor: 5.682

6.  Activated Endolysosomal Cation Channel TRPML1 Facilitates Maturation of α-Synuclein-Containing Autophagosomes.

Authors:  Maike R Pollmanns; Judith Beer; Ines Rosignol; Natalia Rodriguez-Muela; Björn H Falkenburger; Elisabeth Dinter
Journal:  Front Cell Neurosci       Date:  2022-07-06       Impact factor: 6.147

7.  Motor dysfunction in Drosophila melanogaster as a biomarker for developmental neurotoxicity.

Authors:  Ana Cabrita; Alexandra M Medeiros; Telmo Pereira; António Sebastião Rodrigues; Michel Kranendonk; César S Mendes
Journal:  iScience       Date:  2022-06-07

Review 8.  The role of Rab GTPases in the pathobiology of Parkinson' disease.

Authors:  Luis Bonet-Ponce; Mark R Cookson
Journal:  Curr Opin Cell Biol       Date:  2019-05-01       Impact factor: 8.382

Review 9.  Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration.

Authors:  Alazne Arrazola Sastre; Miriam Luque Montoro; Hadriano M Lacerda; Francisco Llavero; José L Zugaza
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 10.  The LRRK2-macroautophagy axis and its relevance to Parkinson's disease.

Authors:  Claudia Manzoni
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.